PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Ortin Global Limited

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Ortin Global Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.

What stands out

  • Cash Locked Ratio: Money owed to suppliers is larger than money owed by customers plus stock: ₹1,228 per ₹100 of sales comes from others' credit, against ₹44 tied up three years earlier. Less money tied up than almost all Healthcare companies in India.
  • Tangible Net Worth Ratio: Of every ₹100 of net worth, ₹100 is tangible; the rest is goodwill and other intangibles, often from buying other companies. More tangible than 98% of Healthcare companies in India.
  • Tangible Assets Ratio: Of every ₹100 the company owns, ₹100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. More tangible than 98% of Healthcare companies in India.

Where ₹100 of sales goes

₹1,131Operating costs₹0.6Interest₹737Net loss

Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

—

Loss-making or profit too small

Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.

Self-Funding Ratio

—

Data incomplete

Cash Locked Ratio

−₹1,228

Money owed to suppliers is larger than money owed by customers plus stock: ₹1,228 per ₹100 of sales comes from others' credit, against ₹44 tied up three years earlier.

Less money tied up than almost all Healthcare companies in India.

Growth quality

Steadiness Ratio

0/3 · 2/3

Sales grew in 0 of the last 3 years; profit grew in 2 of 3.

Less steady than 94% of Healthcare companies in India.

Growth Efficiency Ratio

—

Sales fell 98%

Sales fell 98% in 3 years, so extra profit per extra sales cannot be measured.

Asset Productivity Ratio

-98% / -78%

In 3 years sales changed by -98% while total assets changed by -78%. Assets grew faster than sales.

Balance-sheet strength

Debt Due Cover Ratio

No debt due

No debt falls due within a year, according to the latest yearly balance sheet.

Cash Cushion Ratio

−4%

Debt, after subtracting cash, equals 4% of its market value (net debt).

Lower than 61% of Healthcare companies in India.

Tangible Assets Ratio

100%

Of every ₹100 the company owns, ₹100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

More tangible than 98% of Healthcare companies in India.

Tangible Net Worth Ratio

100%

Of every ₹100 of net worth, ₹100 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

More tangible than 98% of Healthcare companies in India.

Shareholders

Shareholder Slice Ratio

0%

Share count was unchanged over the last 3 years.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (13)

Ortin Global Limited made a loss over the last year. Ortin Global Limited owes ₹0.73 for every ₹1 it owns. Ortin Global Limited made a loss in each of the last two years.

Compared with Healthcare companies in India · latest annual results Mar 2026.

P/E ratio

Loss

Ortin Global Limited made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

8.44

The share price is 8.44 times Ortin Global Limited's book value per share, higher than 80% of Healthcare companies in India.

Market cap

₹10 Cr

The total market value of all of Ortin Global Limited's shares at today's price (share price × number of shares), smaller than almost all Healthcare companies in India. PosiCap size class: Nano Cap.

Net worth (book value)

₹1 Cr

What Ortin Global Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).

Book value per share

₹1.52

Net worth divided by the number of shares. The share price of ₹12.84 is 8.4 times this, which is the P/B above.

Return on equity (ROE)

-84.2%

Ortin Global Limited lost 84.2% of its shareholders' money over the last year, lower than almost all Healthcare companies in India.

Owes vs Owns

0.73×

Ortin Global Limited owes ₹0.73 for every ₹1 it owns (moderate), higher than 97% of Healthcare companies in India.

Dividend yield

None

Ortin Global Limited does not currently pay a dividend.

Revenue growth

-71%

Revenue fell 71% in the year to Mar 2026, and shrank 74% a year on average over 3 years.

Profit growth

Loss

Ortin Global Limited made a loss in each of the last two years.

Profit margin

-736.7%

Ortin Global Limited lost ₹737 for every ₹100 of revenue.

Interest cover

Not covered

Ortin Global Limited's operating profit did not cover its interest costs in the year to Mar 2026.

Cash vs debt

Net debt

Ortin Global Limited had ₹0 Cr more debt than cash (net debt) at Mar 2026.

Questions

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Ortin Global Limited: ₹10 Cr ÷ ₹1 Cr (31 Mar 2026) = 8.4.

What is Ortin Global Limited's return on equity?

Ortin Global Limited lost 84.2% of its shareholders' money over the last year, lower than almost all Healthcare companies in India.

How much does Ortin Global Limited owe compared with what it owns?

Ortin Global Limited owes ₹0.73 for every ₹1 it owns (moderate), higher than 97% of Healthcare companies in India.

Does Ortin Global Limited pay a dividend?

No. Ortin Global Limited does not currently pay a dividend.

Is Ortin Global Limited's revenue growing?

Revenue fell 71% in the year to Mar 2026, and shrank 74% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.